Kidney health
Membranoproliferative glomerulonephritis (MPGN): a rare kidney filter disease
Membranoproliferative glomerulonephritis, or MPGN, is a rare type of kidney damage in which antibodies and complement are deposited in the kidney filters. Some people have no symptoms and it is found on a routine blood test; others notice blood or protein in the urine, swelling or high blood pressure. This guide explains the types, how a kidney biopsy confirms the diagnosis, what treatment aims to do and what the outlook can be.
Last checked: 2026-10-10
Key facts
At a glance.
-
Rare
Kidney Care UK says MPGN affects around 1 in 100,000 people in the UK, and that males and females are affected equally.
-
Can be silent
Kidney Care UK says some people with MPGN do not have any symptoms and the condition is found after a routine blood test shows a drop in kidney function.
-
Diagnosed by biopsy
Kidney Care UK says MPGN is diagnosed by a kidney biopsy, which shows the precise diagnosis and how much damage has been done.
-
Primary or secondary
Secondary MPGN follows other medical problems such as chronic infection like hepatitis or autoimmune conditions like lupus. When no cause is found it is called primary or idiopathic MPGN.
-
Treatment protects the kidneys
Kidney Care UK says treatment for primary MPGN focuses on reducing blood pressure with ACE inhibitors or ARBs, which also reduce protein loss in the urine and slow progress.
-
Long-term risk
Kidney Care UK says half of all people with MPGN will develop kidney failure within 10 years and require dialysis and/or a transplant, although some people have a spontaneous remission.
What MPGN is
The NHS describes glomerulonephritis as damage to the tiny filters inside the kidneys, the glomeruli, often caused by the immune system attacking healthy body tissue. MPGN is one particular pattern of this damage. Kidney Care UK explains that it occurs when antibodies and/or a part of the immune system called complement are deposited in the kidneys, which affects the kidneys' ability to filter the blood and can eventually lead to a reduction in kidney function.
MPGN is also sometimes called mesangiocapillary glomerulonephritis (MCGN). Kidney Care UK says there is a specific subtype of MPGN called C3 glomerulopathy (C3G), and a specific subtype of C3G called dense deposit disease (DDD). The precise diagnosis depends on the location and appearance of the antibody and/or complement deposits within the kidneys.
Because it is rare, MPGN is usually looked after by a specialist kidney (nephrology) team rather than in general practice alone.
Symptoms and signs
Kidney Care UK says some people have no symptoms. When symptoms occur, they include blood in the urine, which may look red or dark brown like a cola drink, is more likely to be noticed after an infection such as a cold or sore throat, and is painless. The blood may be visible only under a microscope. Kidney Care UK adds that the amount of blood is not an indication of severity.
Protein in the urine is another feature; if there is a lot, the urine may look frothy, and the more protein there is, the more severe the condition is. Swelling or puffiness (oedema) may develop, especially around the eyes and ankles, and is caused by the kidneys retaining too much water. High blood pressure and mild or moderate anaemia can also occur.
The NHS lists other possible features of glomerulonephritis, depending on cause, including rashes, joint pain, stomach pain, high temperature, shortness of breath, jaundice, peeing a lot less than usual, tiredness, and loss of appetite and weight loss.
How it is diagnosed
The NHS says that if a GP suspects glomerulonephritis they will usually arrange blood tests to check protein and creatinine and a urine test for blood or protein, and that further tests may include an ultrasound scan and a biopsy. The NHS describes a biopsy as removing a small sample of kidney tissue, carried out using local anaesthetic, with an ultrasound machine used to locate the kidneys.
Kidney Care UK says MPGN is diagnosed by kidney biopsy. Under the microscope, antibodies and/or complement can be seen in the kidney's cells. Blood tests can check complement levels and genetic testing may be offered.
The NHS advises seeing a GP if you notice blood in your urine, which does not always mean glomerulonephritis but should be investigated, or if you have other symptoms such as joint pain, tiredness and shortness of breath.
Causes and family history
Kidney Care UK says MPGN occurs due to a fault in the immune system that causes antibodies and complement to be deposited in the kidneys, and that it is not currently known why this happens. It usually follows other medical problems such as chronic infection like hepatitis or autoimmune conditions like lupus, which is called secondary MPGN. When no cause can be found, it is called primary or idiopathic MPGN.
On inheritance, Kidney Care UK says there is some recent research that MPGN may run in families, but the precise details of any inheritance patterns are still being investigated. The NHS says that if you are diagnosed with an inherited type of glomerulonephritis, a doctor can advise about the chances of someone else in the family being affected.
Treatment and outlook
Treatment for secondary MPGN focuses on the underlying disease, according to Kidney Care UK. For primary MPGN, treatment focuses on reducing blood pressure with ACE inhibitors or ARBs, which also reduce the loss of protein in the urine, slowing progress and preventing or at least delaying further kidney damage. Immunosuppressants such as steroids may be prescribed to help control the immune system. Dietary changes, including a low-salt diet to reduce swelling, may be recommended, and a diuretic may be prescribed.
Kidney Care UK advises that any dietary changes should only be made with advice from a specialist kidney dietitian, and that vitamin D supplements may be recommended if kidney function continues to decline. Dialysis and/or transplant may be needed if kidney damage becomes severe, and MPGN can reoccur in a transplanted kidney.
On outlook, Kidney Care UK says that although some people have a spontaneous remission, in most cases the condition remains active, and half of all people with MPGN will develop kidney failure within 10 years. The NHS notes that complications of glomerulonephritis can include high blood pressure, high cholesterol, blood clots, damage to other organs, chronic kidney disease and kidney failure, and that a doctor may prescribe medicine to help lower blood pressure, lower cholesterol or protect against blood clots.
Support
Kidney Care UK points people to the MPGN/DDD Support Group for more information about diagnosis, symptoms and treatment. Given the long-term nature of the condition, regular monitoring of blood pressure, urine protein and kidney function is part of care, and it is worth asking your kidney team how often you will be reviewed.
Frequently asked
Questions people ask.
Quick, plain-English answers to the questions we hear most.
-
What does MPGN stand for?
Membranoproliferative glomerulonephritis. Kidney Care UK says it is also sometimes called mesangiocapillary glomerulonephritis (MCGN).
-
How rare is MPGN?
Kidney Care UK says it affects around 1 in 100,000 people in the UK, males and females equally.
-
Is C3 glomerulopathy the same thing?
Kidney Care UK describes C3 glomerulopathy as a specific subtype of MPGN, and dense deposit disease as a subtype of C3 glomerulopathy.
-
What symptoms should I look for?
Blood or protein in the urine, swelling around the eyes and ankles and high blood pressure, though Kidney Care UK says some people have no symptoms.
-
How is MPGN confirmed?
By kidney biopsy, according to Kidney Care UK. Blood tests can check complement levels and genetic testing may be offered.
-
Does MPGN run in families?
Kidney Care UK says some recent research suggests it may, but details of inheritance are still being investigated.
-
What treatments are used?
Kidney Care UK lists blood pressure treatment with ACE inhibitors or ARBs, immunosuppressants such as steroids, a low-salt diet and diuretics.
-
Can MPGN lead to kidney failure?
Kidney Care UK says half of all people with MPGN will develop kidney failure within 10 years and need dialysis and/or a transplant, although some have a spontaneous remission.
-
Can it come back after a transplant?
Kidney Care UK says MPGN can reoccur in the transplanted kidney.
Where this comes from
Sources and checking.
This guide is for information, not medical advice.
Your GP or consultant knows your history and can tell you which parts apply to you. If your symptoms are severe, rapidly worsening, or come with red-flag features, seek urgent medical care. Figures and availability change, so treat them as a guide and confirm with the provider.
Published 2026-10-10, next review 2027-10-10.
-
Kidney Care UK: Membranoproliferative glomerulonephritis (MPGN), https://kidneycareuk.org/kidney-disease-information/kidney-conditions/membranoproliferative-glomerulonephritis-mpgn/ , retrieved October 2026
-
NHS: Glomerulonephritis, https://www.nhs.uk/conditions/glomerulonephritis/ , retrieved October 2026
Related guides
Keep reading.
-
Glomerulonephritis
The wider group of conditions that damage the kidney filters.
Read guide -
C3 glomerulopathy
A subtype of MPGN involving complement.
Read guide -
Nephrotic syndrome
Heavy protein loss in the urine with swelling.
Read guide -
Lupus nephritis
Kidney inflammation that can cause secondary MPGN.
Read guide -
Nephrology
The kidney specialty that manages these conditions.
Read guide